Investor Presentations
There are currently no upcoming events...
Altamira Therapeutics to Host Investor Call on September 14th
September 14th, 2022, 10:30 a.m. Eastern Time (7:30 a.m. Pacific Time)
Toll-free dial-in number: 1-877-545-0320
International dial-in number:1-973-528-0002
A replay of the call will be available 30 minutes after the live call via the
Investors section of the Altamira website at https://ir.altamiratherapeutics.com/
Toll Free replay number: 1-877-481-4010
International replay number: 1-919-882-2331
Replay ID: 46517
Expiration: Wednesday September 28, 2022, 11:59 PM ET.
International dial-in number:1-973-528-0002
A replay of the call will be available 30 minutes after the live call via the
Investors section of the Altamira website at https://ir.altamiratherapeutics.com/
Toll Free replay number: 1-877-481-4010
International replay number: 1-919-882-2331
Replay ID: 46517
Expiration: Wednesday September 28, 2022, 11:59 PM ET.
Altamira Therapeutics Sets Full Year 2021 Earnings Call
Tuesday, April 12, 2022, 8:00 a.m. ET
Toll-free Replay: 877-481-4010
International Replay: 919-882-2331
Replay Access Code: 45151
International Replay: 919-882-2331
Replay Access Code: 45151
Altamira Therapeutics Sets Full Year 2021 Earnings Call
Tuesday, April 12, 2022, 8:00 a.m. ET
Toll-free Replay: 877-481-4010
International Replay: 919-882-2331
Replay Access Code: 45151
International Replay: 919-882-2331
Replay Access Code: 45151
Altamira Therapeutics to Host Conference Call and Webcast to Provide Business Update on Bentrio™ Program
Monday, September 27, 2021, at 2:00 pm CEST
To participate telephonically, please dial (888) 506-0062 (U.S.) or (973) 528-0011 (international), conference code 590321.
View Webcast
View Webcast
Supporting Materials:
Altamira Therapeutics Business Update September 2021
Altamira Therapeutics to Report First Half 2021 Financial Results and Provide Business Update
Wednesday, 09/08/21 3:00 pm CEST
Auris Medical Holding Ltd to hold the Special General Meeting
Wednesday, 07/21/21 8:00 am CEST
Description: Auris Medical Holding Ltd will hold the Special General Meeting of Shareholders on July 21, 2021, at 08.00 am CEST in Basel, Switzerland
Supporting Materials:
Auris Medical Notice of the SGM
Auris Medical Holding to Present at LD Micro Invitational XI Conference
Wednesday, 06/09/21 11:00 am EDT
Description: Chairman and CEO Thomas Meyer will present at the LD Micro Invitational XI investor conference on Wednesday June 9, 2021, at 11:00 a.m. EST (Track 2). The event will be webcast live and available via the event homepage.
View Webcast
View Webcast
Auris Medical Business Update June 2021
Thursday, 06/03/21 3:00 pm CEST
Supporting Materials:
Auris Medical Business Update June 2021
Auris Medical to Provide Business Update on AM-301 Program
Tuesday, 04/13/21 8:00 am EDT
Description: Conference Call & Webcast - Rescheduled
Auris Medical will host a conference call and webcast to present a business update. The event will be dedicated in full to the AM-301 program and replace the conference call and webcast which was initially scheduled for March 31, 2021. Further details and webcast information will be provided shortly prior to the event.
Auris Medical will host a conference call and webcast to present a business update. The event will be dedicated in full to the AM-301 program and replace the conference call and webcast which was initially scheduled for March 31, 2021. Further details and webcast information will be provided shortly prior to the event.
Supporting Materials:
Auris Medical Business Update Presentation
